These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20174878)

  • 1. Trends in vaccine-induced immunity to hepatitis B among Canadian street-involved youth.
    Huang L; Gilbert ML; Rossi MF; Haase D; Wright J; Sicard N; Beaudoin C; Taylor D; Gratrix J; Belzak L; Wong T; Jayaraman G
    J Urban Health; 2010 Mar; 87(2):337-348. PubMed ID: 20174878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B infection awareness, vaccine perceptions and uptake, and serological profile of a group of health care workers in Yaoundé, Cameroon.
    Tatsilong HO; Noubiap JJ; Nansseu JR; Aminde LN; Bigna JJ; Ndze VN; Moyou RS
    BMC Public Health; 2016 Aug; 15():706. PubMed ID: 27487845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term immunity to hepatitis B following vaccination in infancy: Real-world data analysis.
    Klinger G; Chodick G; Levy I
    Vaccine; 2018 Apr; 36(17):2288-2292. PubMed ID: 29573878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.
    Mueller A; Stoetter L; Kalluvya S; Stich A; Majinge C; Weissbrich B; Kasang C
    BMC Infect Dis; 2015 Sep; 15():386. PubMed ID: 26399765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center.
    Burton CE; Doucette KE; Mabilangan CA; Plitt SS; Lee BE; Preiksaitis JK
    Transpl Infect Dis; 2016 Aug; 18(4):520-8. PubMed ID: 27226204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia.
    Cheah BC; Davies J; Singh GR; Wood N; Jackson K; Littlejohn M; Davison B; McIntyre P; Locarnini S; Davis JS; Tong SYC
    Vaccine; 2018 Jun; 36(24):3533-3540. PubMed ID: 29735323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the variations of hepatitis B virus status among people having received hepatitis B vaccine].
    Shen LP; Yang JY; Mo ZJ; Li RC; Li YP; Wei ZL; Dong YH; Zhou KJ; Wei SC; Fang KX; Yu T; Zhang WY; Zhang Y; Bi SL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Jul; 28(7):659-62. PubMed ID: 18069553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region.
    Poovorawan Y; Chongsrisawat V; Theamboonlers A; Leroux-Roels G; Kuriyakose S; Leyssen M; Jacquet JM
    J Viral Hepat; 2011 May; 18(5):369-75. PubMed ID: 20384962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
    Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C
    Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of protective anti-HBs antibody levels and anamnestic response to HBV booster vaccination: A cross-sectional study among healthcare students 20 years following the universal immunization campaign in Italy.
    Dini G; Toletone A; Barberis I; Debarbieri N; Massa E; Paganino C; Bersi F; Montecucco A; Alicino C; Durando P
    Hum Vaccin Immunother; 2017 Feb; 13(2):440-444. PubMed ID: 27925503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Hepatitis B Prevalence Among Foreign-Born and U.S.-Born Adults in the United States, 1999-2016.
    Le MH; Yeo YH; Cheung R; Henry L; Lok AS; Nguyen MH
    Hepatology; 2020 Feb; 71(2):431-443. PubMed ID: 31228279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
    Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Aghasadeghi MR; Velayati AA; Mamishi S; Nabavi M; Aghakhani A; Bidari-Zerehpoosh F; Haghi Ashtiani MT; Sabeti S; Banifazl M; Azimian-Zavareh F; Motevalli F; Soleymani S; Ramezani A
    Arch Virol; 2016 Dec; 161(12):3405-3411. PubMed ID: 27613286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
    Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inadequate seroprotection against hepatitis B virus and one detected case of hepatitis C virus infection among patients with inflammatory bowel disease.
    Waszczuk E; Waszczuk KM; Mulak A; Paradowski L
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):628-32. PubMed ID: 26904976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study.
    Sagnelli E; Stroffolini T; Sagnelli C; Morisco F; Coppola N; Smedile A; Pisaturo M; Colloredo G; Babudieri S; Licata A; Brancaccio G; Andriulli A; Almasio PL; Gaeta GB;
    J Med Virol; 2017 Dec; 89(12):2138-2143. PubMed ID: 28608566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High level of exposure to hepatitis B virus infection in a vulnerable population of a low endemic area: A challenge for vaccination coverage.
    Weis-Torres SMDS; Fitts SMF; Cardoso WM; Higa Junior MG; Lima LA; Bandeira LM; Castro VOL; Carneiro FA; Iglecias LMM; Cesar GA; Tanaka TSO; Puga MAM; Rezende GR; Croda J; Lago BV; Motta-Castro ARC
    Int J Infect Dis; 2020 Jan; 90():46-52. PubMed ID: 31589921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.
    Simons BC; Spradling PR; Bruden DJ; Zanis C; Case S; Choromanski TL; Apodaca M; Brogdon HD; Dwyer G; Snowball M; Negus S; Bruce MG; Morishima C; Knall C; McMahon BJ
    J Infect Dis; 2016 Jul; 214(2):273-80. PubMed ID: 27056956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.